Clinical and Histopathological Evolution of Endometrial Cancer Care Before, After and During the COVID-19 Pandemic: A Longitudinal Institutional Study
This longitudinal study of 101 endometrial cancer patients reveals that while the COVID-19 pandemic did not alter tumor stage distribution, it significantly prolonged diagnostic delays, shortened hospital stays, increased psycho-oncologic support needs during the crisis, and was associated with a higher prevalence of lymphovascular space invasion in the recovery phase, highlighting the complex impact of healthcare disruptions on clinical outcomes beyond traditional staging metrics.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Endometrial cancer, often called cancer of the uterine lining, is the most common gynecologic malignancy in developed nations. It typically arises in women who have gone through menopause, frequently signaled by unexpected bleeding. The disease is strongly linked to lifestyle factors such as obesity and diabetes, which can alter hormone levels and fuel tumor growth. In a standard medical setting, doctors move quickly from the first sign of bleeding to a diagnosis, often using ultrasound and a small tissue sample, followed by surgery to remove the uterus. This path is designed to catch the cancer early, before it spreads, and to treat it with the least amount of disruption to the patient's life. However, when a global crisis strikes, the machinery of healthcare can grind to a halt, forcing doctors to make impossible choices about who gets treated and when. The question for oncologists is not just whether patients survive the virus, but whether the necessary delays and changes in routine care during a pandemic leave them more vulnerable to the cancer itself.
Researchers at a university hospital in Frankfurt, Germany, set out to trace exactly how the COVID-19 pandemic altered the journey of women with endometrial cancer. They looked at 101 patients treated over several years, dividing them into three groups: those treated before the pandemic began, those treated during the height of the crisis, and those treated as the world began to recover. By comparing these groups against the pre-pandemic period, which served as their baseline for normal care, the team could see how the system adapted and where it stumbled. They examined not just the stage of the cancer at diagnosis, but also the time it took to start treatment, the type of surgery performed, how long patients stayed in the hospital, and the presence of specific microscopic features that indicate how aggressive a tumor might be.
The study revealed that the pandemic did not cause a dramatic shift in the overall stage of the disease at the time of diagnosis. The proportion of women with early-stage cancer versus advanced cancer remained statistically similar across all three time periods. This suggests that the hospital's ability to identify and prioritize these cases held firm, even when resources were stretched thin. However, the timeline of care was significantly disrupted. In the period following the acute crisis, the time between a patient's first contact with the hospital and the start of their therapy grew longer. While patients before the pandemic waited an average of about 12 days to begin treatment, those in the recovery phase waited nearly 17 days. This delay likely reflects a backlog of cases that accumulated as routine services were paused and then had to catch up.
During the peak of the pandemic itself, the hospital operated differently to cope with the strain. Patients spent less time in the hospital after surgery, with an average stay of roughly 5.8 days compared to nearly 8 days before the crisis. To achieve this, doctors relied more heavily on minimally invasive techniques, such as laparoscopy, which uses small incisions and a camera, rather than large open surgeries. They also performed fewer extensive lymph node removals during the pandemic, likely to shorten procedures and reduce the time patients spent in the operating room. Despite these changes, the rate of surgical complications did not increase, indicating that the adapted methods remained safe.
The most striking finding emerged when the researchers looked at the microscopic details of the tumors after the pandemic had passed. In the recovery cohort, the researchers found a statistically significant increase in a feature called lymphovascular space invasion. This occurs when cancer cells are found inside the tiny blood vessels or lymph channels within the tumor tissue, a sign that the cancer has the potential to spread more easily. This feature appeared in about 23.5 percent of the patients treated after the pandemic, compared to only 8.1 percent of those treated before it. While the overall stage of the cancer did not change, this shift in the tumor's biological risk profile suggests that the disruptions in care may have allowed more aggressive forms of the disease to go undetected or untreated for longer.
The human cost of these systemic shifts was also visible in the data. During the acute phase of the pandemic, the need for psychological support among patients surged. More than half of the women treated during the crisis utilized psycho-oncologic services, a rate more than double that of the recovery period. This highlights how the fear and isolation of the pandemic compounded the stress of a cancer diagnosis. The study concludes that while the hospital managed to prevent a large-scale shift toward more advanced cancer stages, the pandemic left a subtle but measurable mark on the disease. The delays in treatment and the changes in surgical approach appear to have influenced the biological characteristics of the tumors, underscoring that the true impact of a healthcare crisis extends beyond simple staging metrics to the very nature of the disease itself.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.